WIC
ABBV icon

Wilkins Investment Counsel’s AbbVie ABBV Stock Holding History

Wilkins Investment Counsel’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.73M Buy
14,832
+650
+5% +$140K 0.5% 48
2026
Q1 		$3.08M Sell
14,182
-210
-1% -$46.6K 0.44% 48
2025
Q4 		$3.29M Hold
14,392
– – 0.48% 48
2025
Q3 		$3.33M Sell
14,392
-180
-1% -$36.7K 0.47% 47
2025
Q2 		$2.7M Sell
14,572
-800
-5% -$149K 0.38% 47
2025
Q1 		$3.22M Sell
15,372
-410
-3% -$79.7K 0.46% 46
2024
Q4 		$2.8M Sell
15,782
-50
-0.3% -$9.19K 0.41% 51
2024
Q3 		$3.13M Sell
15,832
-825
-5% -$154K 0.43% 48
2024
Q2 		$2.86M Sell
16,657
-200
-1% -$33.1K 0.43% 48
2024
Q1 		$3.07M Buy
+16,857
New +$2.91M 0.45% 48

Other funds holding ABBV

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Wilkins Investment Counsel's ABBV Position: Q2 2026 in Review

Wilkins Investment Counsel increased its AbbVie (ABBV) stake by 4.6% in Q2 2026, buying an estimated $140K and bringing the position to 14,832 shares worth $3.73M. The position accounts for 0.5% of the portfolio, ranked #48.

Wilkins Investment Counsel first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. 2,655 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Wilkins Investment Counsel held 14,832 shares of AbbVie worth $3.73M as of Q2 2026.
  • Wilkins Investment Counsel bought 650 AbbVie shares in Q2 2026, an estimated $140K.
  • AbbVie made up 0.5% of Wilkins Investment Counsel's portfolio in Q2 2026, its #48 holding.
  • Wilkins Investment Counsel first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
  • 2,655 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wilkins Investment Counsel's 13F filing for Q2 2026, filed 6 Aug 2026.